Healthcare/Hospital Law
Oct. 18, 2001
Risky Medicine
Over the past year, the Food and Drug Administration and the Office of Human Research Protections of the Department of Health and Human Services have suspended clinical-research studies at several institutions due to deficiencies in human-research protection systems.
Over the past year, the Food and Drug Administration and the Office of Human Research Protections of the Department of Health and Human Services have suspended clinical-research studies at several institutions due to deficiencies in human-research protection systems.
&...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In